Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Evocutis (trading assets)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of skin-care products. The portfolio includes contract research assays associated with Labskin, plus in vitro skin models, skin microbiology expertise and clinical trial support services focused entirely on dermatology.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • Suite 3B, 38 Jermyn Street
  • London SW1Y 6DN
  • England, United Kingdom

Evocutis (trading assets) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Evocutis (trading assets)‘s full profile, request access.

Request full access to PitchBook

Evocutis (trading assets) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Evocutis (trading assets)‘s full profile, request access.

Request full access to PitchBook